Bristol-Myers Squibb Company
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Bristol-Myers Squibb Company (BMY) Business News
Track Bristol-Myers Squibb Company in real time with a live news feed covering Bristol-Myers Squibb Company stock news, official press releases, company announcements, and an archive of historical Bristol-Myers Squibb Company news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
My Top 4 Pharma Picks Under Rising Geopolitical Risk
Carnegie Investment Counsel Sells 10,008 Shares of Bristol Myers Squibb Company $BMY
My Top 4 Pharma Picks Under Rising Geopolitical Risk
Carnegie Investment Counsel Sells 10,008 Shares of Bristol Myers Squibb Company $BMY
Which Dividend Pharma Stock Should a Value Investor Choose Today?
2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap
Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours
Bristol Myers Squibb (BMY) Rises Higher Than Market: Key Facts
Leo Wealth LLC Grows Stock Holdings in Bristol Myers Squibb Company $BMY
Savvy Advisors Inc. Acquires 9,893 Shares of Bristol Myers Squibb Company $BMY
Perpetual Ltd Purchases 36,562 Shares of Bristol Myers Squibb Company $BMY
Element Squared LLC Acquires Shares of 48,420 Bristol Myers Squibb Company $BMY
Autoimmune diseases, oncology, and type 2 diabetes continue to spread around the world, but these stocks stay off investors' radars. Many of them consistently beat Street's consensus forecasts and offer dividend yields even higher than oil and gas stocks, as well as the "Magnificent 7." By opening this article, you will find out my "top 4 Big Pharma players."
Read full article
My Top 4 Pharma Picks Under Rising Geopolitical Risk
Seeking AlphaAutoimmune diseases, oncology, and type 2 diabetes continue to spread around the world, but these stocks stay off investors' radars. Many of them consistently beat Street's consensus forecasts and offer dividend yields even higher than oil and gas stocks, as well as the "Magnificent 7." By opening this article, you will find out my "top 4 Big Pharma players."
Read full article
Carnegie Investment Counsel Sells 10,008 Shares of Bristol Myers Squibb Company $BMY
Defense WorldCarnegie Investment Counsel reduced its holdings in shares of Bristol Myers Squibb Company (NYSE: BMY) by 35.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,153 shares of the biopharmaceutical company's stock after selling 10,008 shares during the quarter. Carnegie
Read full article
My Top 4 Pharma Picks Under Rising Geopolitical Risk
Seeking AlphaAutoimmune diseases, oncology, and type 2 diabetes continue to spread around the world, but these stocks stay off investors' radars. Many of them consistently beat Street's consensus forecasts and offer dividend yields even higher than oil and gas stocks, as well as the "Magnificent 7." By opening this article, you will find out my "top 4 Big Pharma players."
Read full article
Carnegie Investment Counsel Sells 10,008 Shares of Bristol Myers Squibb Company $BMY
Defense WorldCarnegie Investment Counsel reduced its holdings in shares of Bristol Myers Squibb Company (NYSE: BMY) by 35.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,153 shares of the biopharmaceutical company's stock after selling 10,008 shares during the quarter. Carnegie
Read full article
Which Dividend Pharma Stock Should a Value Investor Choose Today?
The Motley FoolValues aren't always easy to find in the pharma sector. Bristol Myers Squibb has stable revenue, plus a strong dividend payout.
Read full article
2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap
The Motley FoolCVS Health and Bristol Myers Squibb are built to handle the toughest recessions. Both companies have maintained or increased their dividends through downturns over the past two decades.
Read full article
Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours
GlobeNewsWireOxford, UK and San Jose, California , 9 April 2026 – Oxford BioTherapeutics (“OBT”), is a clinical stage oncology company focused on the discovery and development of immuno-oncology (IO) and Antibody Drug Conjugate (ADC)-based therapies enabled by its OGAP®-Verify platform today announced a multi-year, selective target collaboration with Bristol Myers Squibb (NYSE: BMY, “BMS”) focussed on the discovery and development of novel T-cell engager therapies for solid tumours.
Read full article
Bristol Myers Squibb (BMY) Rises Higher Than Market: Key Facts
Zacks Investment ResearchIn the most recent trading session, Bristol Myers Squibb (BMY) closed at $59.2, indicating a +2.65% shift from the previous trading day.
Read full article
Leo Wealth LLC Grows Stock Holdings in Bristol Myers Squibb Company $BMY
Defense WorldLeo Wealth LLC increased its stake in Bristol Myers Squibb Company (NYSE: BMY) by 36.8% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,134 shares of the biopharmaceutical company's stock after acquiring an additional 14,033 shares
Read full article
Savvy Advisors Inc. Acquires 9,893 Shares of Bristol Myers Squibb Company $BMY
Defense WorldSavvy Advisors Inc. raised its holdings in shares of Bristol Myers Squibb Company (NYSE: BMY) by 20.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 57,170 shares of the biopharmaceutical company's stock after purchasing an additional 9,893 shares during the period. Savvy Advisors Inc.
's holdings
Perpetual Ltd Purchases 36,562 Shares of Bristol Myers Squibb Company $BMY
Defense WorldPerpetual Ltd raised its position in shares of Bristol Myers Squibb Company (NYSE: BMY) by 121.2% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,741 shares of the biopharmaceutical company's stock after buying an additional 36,562 shares during the
Read full article
Element Squared LLC Acquires Shares of 48,420 Bristol Myers Squibb Company $BMY
Defense WorldElement Squared LLC bought a new position in Bristol Myers Squibb Company (NYSE: BMY) in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 48,420 shares of the biopharmaceutical company's stock, valued at approximately $2,612,000. Bristol Myers Squibb makes up approximately
Read full article